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Volume 57, Number 5S Abstracts 49Swithout CO (8.63% vs 3.5%; P ¼ .006 and 5.75% vs 1.94%;
P ¼ .009 respectively).
Factors associated to the highest risk in patients with
CO were age >74 years and presence of preoperative brain
infarct (P < .04). The association of CO, age >74 ys and
preoperative brain infarct signiﬁcantly increase the risk of
post-CEA neurological complication occurrence in the
population submitted to CEA (OR, 21.9; 95% CI, 6.6-
74; P < .0001).
Conclusions: Patients presenting a carotid stenosis
with CO are at high neurological risk when submitted to
CEA. In this group of patients those presenting >74 years
of age and a preoperative brain infarct represent a subset at
highest neurological risk following CEA.
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Objectives: Outcome analysis for carotid endarterec-
tomy (CEA) and carotid angioplasty and stenting (CAS)
using administrative data is hampered by difﬁculty in distin-
guishing pre-existing conditions (eg symptomatic carotid
stenosis) from postoperative complications (eg stroke).
We evaluated whether the introduction of the present on
admission (POA) indicator improved the accuracy of
administrative databases.
Methods: State inpatient databases from CA, NY and
NJ from 2005-2008 were used to identify patients under-
going CAS and CEA. Procedural complications were iden-
tiﬁed using ICD-9 complication codes (eg 997.02,
postoperative stroke). Preoperative conditions were identi-
ﬁed using ICD-9 diagnosis codes (eg, 433.11, carotid
stenosis with infarction). We ﬁrst analyzed the data
without, and then with the POA information.
Results: We identiﬁed 36,002 patients who under-
went CEA and 5682 patients who underwent CAS.
Without POA info, the complication code for stroke indi-
cated a postoperative stroke rate of 1.1% for CEA and
1.9% for CAS. After applying the POA indicator, only
59% (CEA) and 50% (CAS) of these actually referred to
perioperative strokes while the remainder were POA and
thus represented pre-existing strokes. POA info high-
lighted inaccuracies in morbidity data for both complica-
tion and diagnosis codes (Table).
Conclusions: The assumption that complication
codes following CAS or CEA refer to perioperative adverse
events proved to be incorrect, as great proportions appear
to have been POA. The reclassiﬁcation of indications and
complications raise concerns about the validity of adminis-
trative data.Table.
CEA CASRate w/o
POA info POA, %Rate w/o
POA info POA, %Stroke complication code 1.1 41 1.9 50
Cardiac complication code 2.3 45 2.5 50
Stroke diagnosis codes 5.7 86 10.6 87
TIA diagnosis codes 1.9 92 2.5 83
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Objectives: Patients in CREST had duplex ultrasound
(DU) scans prior to treatment (PRE) and during follow-up
(FU) to document the severity of carotid disease and the
outcome of endarterectomy (CEA) or stenting (CAS).
An ultrasound core laboratory (UCL) reviewed DU data
from the clinical sites. This analysis was done to determine
the agreement between site-reported and UCL-veriﬁed
DU velocity measurements.
Methods: Clinical site DU worksheets and images
for the treated carotid arteries were reviewed at the
UCL. The highest internal carotid artery peak systolic
velocity (PSV) and associated Doppler angle were veri-
ﬁed. If the angle was misaligned by >3 degrees, it was
remeasured and PSV recalculated. Agreement for PSV
was deﬁned as site-reported PSV within 65% of UCL-
veriﬁed PSV. Transcription errors were corrected by the
UCL but were not considered as disagreements. FU
